Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A

Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A

SSZSE:301234
103.88
CNY
+1.78
(+1.74%)
0.26EPS
514.85P/E
9.22BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A carries a market capitalization of 9.22B, placing it among publicly traded companies globally. Its enterprise value stands at 8.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.22B
Enterprise Value8.81B

Share Statistics

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A has 68.00M shares outstanding.

Shares Outstanding68.00M

Valuation Ratios

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 514.85. The price-to-sales ratio is 22.33, and the price-to-book ratio stands at 12.06.

PE Ratio514.85
PS Ratio22.33
PB Ratio12.06
P/TBV Ratio12.16

Enterprise Valuation

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A trades at an EV/EBITDA multiple of 422.70 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 21.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 422.70 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 8.81B versus a market cap of 9.22B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales21.33
EV / EBITDA422.70
EV / EBIT422.70

Financial Position

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A maintains a current ratio of 6.69, meaning it holds 6.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.06, indicating conservative leverage, while an interest coverage ratio of 1,897.80 demonstrates limited ability to service its debt obligations.

Current Ratio6.69
Quick Ratio4.88
Debt / Equity0.06
Debt / EBITDA0.02
Interest Coverage1,897.80

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A posted a return on equity (ROE) of 2.36, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.42 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.08, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.36, useful for judging operating efficiency across full business cycles. The company generates approximately 482,515.72 in revenue per employee across its workforce of 856.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.62 indicates how many times Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)2.36
Return on Assets (ROA)2.08
Return on Invested Capital (ROIC)2.42
Return on Capital Employed (ROCE)2.36
Revenue Per Employee482,515.72
Employee Count856.00
Inventory Turnover6.62

Taxes

CNY

Over the twelve months ended September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A recorded 2.37M in income tax expense. That works out to an effective tax rate of 11.69, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 20.29M, leaving 17.92M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax2.37M
Effective Tax Rate11.69

Stock Price Statistics

CNY

As of the close on November 17, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A's stock has gained approximately 158.54% over the past 52 weeks. The 50-day moving average sits at 120.15, while the 200-day moving average is 65.98.

52-Week Price Change158.54%
50-Day Moving Average120.15
200-Day Moving Average65.98

Income Statement

CNY

Over the twelve months ended September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A generated 413.03M in revenue and converted that into 17.92M in net income, yielding earnings per share of 0.26. EBITDA reached 20.84M, while operating income came in at 23.47M.

Revenue413.03M
Gross Profit68.88M
Operating Income23.47M
Pretax Income20.29M
Net Income17.92M
EBITDA20.84M
EBIT20.84M
Earnings Per Share (EPS)0.26

Balance Sheet

CNY

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A holds 413.99M in cash and equivalents against 495,567.85 in total debt, resulting in a net debt position of -58.12M. Total book value stands at 765.01M, with working capital of 482.34M providing operational flexibility.

Cash & Cash Equivalents413.99M
Total Debt495,567.85
Net Debt-58.12M
Equity (Book Value)765.01M
Book Value Per Share11.25
Working Capital482.34M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-36.94M

Margins

Over the twelve months ended September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A posted a gross margin of 16.68, reflecting its pricing power and cost economics. The operating margin of 5.68 and net profit margin of 4.34 provide insight into operational efficiency.

Gross Margin16.68
Operating Margin5.68
Pretax Margin4.91
Profit Margin4.34
EBITDA Margin5.05

Scores

As of September 30, 2026, Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A has an Altman Z-Score of 56.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score56.83